On July 30, Acadia Healthcare fell 15.57% in regular trading, trading at $27.59/share, with turnover of $139 million. The sharp decline followed the company's Q2 earnings report released after market close on July 28.

While Acadia Healthcare posted Q2 adjusted EPS of $0.38, beating the FactSet consensus estimate of $0.35, the figure represented a 54% decline from $0.83 in the year-ago period. Revenue came in at $865.8 million, also exceeding the $844.2 million estimate, but still reflected a year-over-year decline. The company updated its full-year guidance, projecting revenue of $3.40 billion to $3.45 billion, roughly in line with the FactSet estimate of $3.41 billion.

The steep profit erosion reflects ongoing headwinds including a New York State Medicaid policy change expected to negatively impact adjusted EBITDA by $25-$30 million. Acadia Healthcare is a leading U.S. behavioral healthcare provider operating 262 facilities with approximately 11,850 beds across 39 states.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)